Krabbe disease

WikiDoc Resources for Krabbe disease
Articles
Most recent articles on Krabbe disease Most cited articles on Krabbe disease Review articles on Krabbe disease Articles on Krabbe disease in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Krabbe disease Images of Krabbe disease Photos of Krabbe disease Podcasts & MP3s on Krabbe disease Videos on Krabbe disease
Evidence Based Medicine
Cochrane Collaboration on Krabbe disease Bandolier on Krabbe disease TRIP on Krabbe disease
Clinical Trials
Ongoing Trials on Krabbe disease at Clinical Trials.gov Trial results on Krabbe disease Clinical Trials on Krabbe disease at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Krabbe disease NICE Guidance on Krabbe disease NHS PRODIGY Guidance FDA on Krabbe disease CDC on Krabbe disease
Books
Books on Krabbe disease
News
Krabbe disease in the news Be alerted to news on Krabbe disease News trends on Krabbe disease
Commentary
Blogs on Krabbe disease
Definitions
Definitions of Krabbe disease
Patient Resources / Community
Patient resources on Krabbe disease Discussion groups on Krabbe disease Patient Handouts on Krabbe disease Directions to Hospitals Treating Krabbe disease Risk calculators and risk factors for Krabbe disease
Healthcare Provider Resources
Symptoms of Krabbe disease Causes & Risk Factors for Krabbe disease Diagnostic studies for Krabbe disease Treatment of Krabbe disease
Continuing Medical Education (CME)
CME Programs on Krabbe disease
International
Krabbe disease en Espanol Krabbe disease en Francais
Business
Krabbe disease in the Marketplace Patents on Krabbe disease
Experimental / Informatics
List of terms related to Krabbe disease

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Krabbe disease
ICD-10	E75.2
ICD-9	330.0
OMIM	245200
DiseasesDB	29468
eMedicine	ped/2892
MeSH	D007965

Overview

Krabbe disease (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare, often fatal degenerative disorder that affects the nervous system. This condition is inherited in an autosomal recessive pattern. It is caused by the shortage (deficiency) of an enzyme called galactosylceramidase. This enzyme deficiency impairs the growth and maintenance of myelin, the protective covering around certain nerve cells that ensures the rapid transmission of nerve impulses. Krabbe disease is part of a group of disorders known as leukodystrophies, which result from the loss of myelin (demyelination). This disorder is also characterized by the abnormal presence of globoid cells, which are globe-shaped cells that usually have more than one nucleus.

The symptoms of Krabbe disease usually begin before the age of 1 year (the infantile form). Initial signs and symptoms typically include irritability, muscle weakness, feeding difficulties, episodes of fever without any sign of infection, stiff posture, and slowed mental and physical development. As the disease progresses, muscles continue to weaken, affecting the infant's ability to move, chew, swallow, and breathe. Affected infants also experience vision loss and seizures.

Less commonly, onset of Krabbe disease can occur in childhood, adolescence, or adulthood (late-onset forms). Visual problems and walking difficulties are the most common initial symptoms in this form of the disorder, however, signs and symptoms vary considerably among affected individuals.

Historical Perspective

Advocacy

Former Buffalo Bills quarterback Jim Kelly has been a leader in gaining recognition and research funding for the disease, following the diagnosis of his son, Hunter, with Krabbe disease in 1997. Hunter Kelly died of the disease August 5, 2005 at the age of 8. He was the longest known living survivor of infantile Krabbe disease.

Classification

Presentation

Infants with Krabbe disease are normal at birth. Symptoms begin between the ages of 3 and 6 months with irritability, inexplicable crying, fevers, limb stiffness, seizures, feeding difficulties, vomiting, and slowing of mental and motor development. In the first stages of the disease, doctors often mistake the symptoms with those of cerebral palsy. Other symptoms include muscle weakness, spasticity, deafness, optic atrophy and blindness, paralysis, and difficulty when swallowing. Prolonged weight loss may also occur. There are also juvenile- and adult-onset cases of Krabbe disease, which have similar symptoms but slower progression.

Incidence

Worldwide, Krabbe disease occurs in about 1 in 100,000–200,000 births. A higher incidence (6 cases per 1,000 live births) has been reported in a few isolated arab communities in Israel.

Causes

Krabbe disease is caused by mutations in the GALC gene, which causes a deficiency of an enzyme called galactosylceramidase. The buildup of undigested fats affects the growth of the nerve’s protective myelin sheath (the covering that insulates many nerves) and causes severe degeneration of mental and motor skills. As part of a group of disorders known as leukodystrophies, Krabbe disease results from the imperfect growth and development of myelin.

Natural History, Complications, and Prognosis

In infants, the disease is generally fatal before age 2. Patients with a later onset form of the disease have a milder course of the disease and live significantly longer.

Diagnosis

The disease may be diagnosed by its characteristic grouping of certain cells (multinucleated globoid cells), nerve demyelination and degeneration, and destruction of brain cells. Special stains for myelin (e.g; luxol fast blue) may be used to aid diagnosis.

Treatment

Although there is no cure for Krabbe disease, bone marrow transplantation has been shown to benefit mild cases early in the course of the disease. Generally, treatment for the disorder is symptomatic and supportive. Physical therapy may help maintain or increase muscle tone and circulation. A recent study in the New England Journal of Medicine reports that cord blood transplants have been successful in stopping the disease as long as they are given before overt symptoms appear.

Prevention

This article incorporates public domain text from The U.S. National Library of Medicine and the National Institute of Neurological Disorders and Stroke. [2]

External links

• The Stennis Foundation
• The Stennis Foundation's MySpace site
• Hunter's Hope Foundation
• [3]
• [4]
• Template:Chorus
• Template:WhoNamedIt

See also

• The Myelin Project
• The Stennis Foundation

References

Template:WikiDoc Sources